Demographics and Baseline Characteristics of Children With Atopic Dermatitis Enrolled in a Randomized Phase 3 Study (TRuE-AD3)

被引：0
|
作者：
Siri, Dareen [1 ]
Lee, Lara Wine [2 ]
Gold, Linda Stein [3 ]
Armstrong, April [4 ]
Brar, Kanwaljit [5 ]
Holland, Kristen [6 ]
Shepard, Julie [7 ]
Devani, Alim [8 ]
Sturm, Daniel [9 ]
Angel, Brett [9 ]
Li, Qian [9 ]
Eichenfield, Lawrence [10 ]
机构：
[1] Midwest Allergy Sinus Asthma, Bloomington, IL USA
[2] Med Univ South Carolina, Charleston, SC USA
[3] Henry Ford Hlth Syst, Detroit, MI USA
[4] Univ Calif Los Angeles, Div Dermatol, Los Angeles, CA USA
[5] NYU Langone Hlth Ctr, Hassenfeld Childrens Hosp, New York, NY USA
[6] Med Coll Wisconsin, Milwaukee, WI USA
[7] Ohio Pediat Res Assoc, Dayton, OH USA
[8] Dermatol Res Inst, Calgary, AB, Canada
[9] Incyte Corp, Wilmington, DE USA
[10] Univ Calif San Diego, San Diego, CA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2024年 / 153卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
021
引用
收藏
页码：AB8 / AB8
页数：1
相关论文
共 50 条
  • [41] Dupilumab in moderate-to-severe atopic dermatitis by history of asthma and allergic rhinitis: Analysis from a 52 week randomized phase 3 trial (liberty ad chronos)
    Prens, E.
    De Bruin-Weller, M.
    Ettler, K.
    Etoh, T.
    Seo, S.
    Chen, Z.
    Graham, N. M. H.
    Pirozzi, G.
    Hultsch, T.
    Eckert, L.
    Gadkari, A.
    Akinlade, B.
    Shumel, B.
    ALLERGY, 2018, 73 : 78 - 79
  • [42] Baseline characteristics of phase 3 randomized controlled trials of omalizumab in chronic rhinosinusitis with nasal polyps
    Bachert, C.
    Gevaert, P.
    Corren, J.
    Mullol, J.
    Han, J.
    Ow, R.
    Hussain, I
    Islam, L.
    Fogel, R.
    Kaufman, D.
    Omachi, T.
    ALLERGY, 2019, 74 : 329 - 330
  • [43] BASELINE CHARACTERISTICS OF CHILDREN AND ADOLESCENTS WITH CLASSIC CONGENITAL ADRENAL HYPERPLASIA ENROLLED IN CAHTALYST PEDIATRIC, A PHASE 3 STUDY OF CRINECERFONT, A CORTICOTROPIN-RELEASING FACTOR TYPE 1 RECEPTOR ANTAGONIST
    Sarafoglou, Kyriakie
    Kim, Mimi S.
    Lodish, Maya
    Felner, Eric I.
    Nokoff, Natalie
    Fechner, Patricia Y.
    Vogiatzi, Maria G.
    Speiser, Phyllis W.
    Sturgeon, Julia
    Roberts, Eiry
    Jeha, George S.
    Chan, Jean L.
    Farber, Robert
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 22 - 23
  • [44] PHASE 3 FRACTURE TRIAL OF ODANACATIB FOR OSTEOPOROSIS - BASELINE CHARACTERISTICS AND STUDY DESIGN
    Papapoulos, Socrates
    Bone, Henry
    Dempster, David
    Eisman, John
    Greenspan, Susan
    Mcclung, Michael
    Nakamura, Toshitaka
    Shih, Joseph
    Leung, Albert
    Santora, Arthur
    Verbruggen, Nadia
    Lombardi, Antonio
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S151 - S151
  • [45] Effect of upadacitinib on atopic hand eczema in patients with moderate-to-severe atopic dermatitis: Results from two randomized phase 3 trials
    Simpson, E. L.
    Rahawi, K.
    Hu, X.
    Chu, A. D.
    Nduaka, C.
    Jazayeri, S.
    Lio, P.
    Lynde, C.
    Schuttelaar, M. L. A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, : 1863 - 1870
  • [46] Phase 3 Fracture Trial Of Odanacatib For Osteoporosis - Baseline Characteristics and Study Design
    Papapoulos, Socrates
    Bone, Henry G.
    Dempster, David W.
    Eisman, John
    Greenspan, Susan
    McClung, Michael
    Nakamura, Toshitaka
    Shih, Joseph
    Leung, Albert
    Santora, Arthur
    Verbruggen, N.
    Lombardi, Antonio
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S515 - S516
  • [47] Rapid and sustained improvement in itch in children aged 6-11 years with severe atopic dermatitis (AD) treated with dupilumab: analysis from the LIBERTY AD PEDS phase 3 trial
    Yosipovitch, Gil
    Silverberg, Jonathan I.
    Wu, Jashin J.
    Chen, Zhen
    Abramova, Alvina
    Prescilla, Randy
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (01) : 89 - 89
  • [48] Disease Characteristics and Burden in Patients With Atopic Dermatitis: Insights From Two Phase 3 Studies of Ruxolitinib Cream
    Simpson, Eric
    Lee, Mark
    Brar, Kanwaljit
    Kuligowski, Michael
    Venturanza, May
    Sun, Kang
    Toth, Darryl
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB35 - AB35
  • [49] A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up
    Cather, Jennifer
    Young, Melodie
    DiRuggiero, Douglas C.
    Tofte, Susan
    Williams, Linda
    Gonzalez, Tayler
    DERMATOLOGY AND THERAPY, 2022, 12 (09) : 2013 - 2038
  • [50] A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up
    Jennifer Cather
    Melodie Young
    Douglas C. DiRuggiero
    Susan Tofte
    Linda Williams
    Tayler Gonzalez
    Dermatology and Therapy, 2022, 12 : 2013 - 2038
12345